One-year resource utilisation, costs and quality of life in patients with acute respiratory distress syndrome (ARDS): secondary analysis of a randomised controlled trial

Table 3 Quality of life

	6 months	12 months	Quality-adjusted survival at 12 months
	Mean EQ5D index (95 % CI)	Mean EQ5D index (95 % CI)	Mean QALY (95 % CI)
All patients	0.5622 (0.5163–0.6081)	0.5831 (0.5348–0.6314)	0.2676 (0.2457–0.2894)
Age
<65	0.55 (0.49–0.60)	0.58 (0.53-0.64)	0.31 (0.28-0.35)
≥65	0.62 (0.52–0.71)	0.58 (0.48–0.68)	0.16 (0.12–0.21)
Gender
Male	0.57 (0.51–0.63)	0.58 (0.52–0.64)	0.27 (0.23–0.30)
Female	0.55 (0.47–0.63)	0.59 (0.51–0.67)	0.27 (0.23–0.31)
APACHE II
<26	0.57 (0.52–0.62)	0.57 (0.52–0.63)	0.29 (0.26–0.33)
≥26	0.48 (0.34–0.61)	0.60 (0.50–0.71)	0.16 (0.12–0.20)
PaO2:FiO2 ratio (KPa)
<15	0.57 (0.51–0.64)	0.58 (0.51–0.65)	0.23 (0.20–0.27)
≥15	0.55 (0.48–0.63)	0.59 (0.52–0.65)	0.31 (0.27–0.35)
Ventilation method
Conventional	0.52 (0.45–0.59)	0.55 (0.48–0.61)	0.25 (0.21–0.29)
HFOV	0.61 (0.54–0.67)	0.62 (0.55–0.69)	0.29 (0.25–0.33)